Delayed Graft Function clinical trials at UCSF

• Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney

  open to eligible people ages 18 years and up

  The major objective is to demonstrate the safety and efficacy of ANG-3777 in improving graft function and reducing the severity of delayed graft function (DGF) in recipients at high risk of DGF after receiving a deceased donor renal allograft.

  San Francisco, California and other locations

• Deceased Organ Donor Interventions to Protect Kidney Graft Function

  Sorry, not currently recruiting here

  To protect kidney function during the transplantation process by comparing mild hypothermia in the deceased organ donor before organs are recovered and pulsatile perfusion of the kidney after recovery and prior to transplantation.

  San Francisco, California and other locations

Last updated: September 11, 2020